KVÅKVÅ3E00X29 — Introduction of Other Anti-infective into Skin and Mucous Membranes, External Approach
KVÅKVÅ3E0132A — Introduction of Anti-Infective Envelope into Subcutaneous Tissue, Percutaneous Approach
KVÅKVÅ3E0D729 — Introduction of Other Anti-infective into Mouth and Pharynx, Via Natural or Artificial Opening
KVÅKVÅ3E0D73Z — Introduction of Anti-inflammatory into Mouth and Pharynx, Via Natural or Artificial Opening
KVÅKVÅ3E0E329 — Introduction of Other Anti-infective into Products of Conception, Percutaneous Approach
KVÅKVÅ3E0E729 — Introduction of Other Anti-infective into Products of Conception, Via Natural or Artificial Opening
KVÅKVÅ3E0E73Z — Introduction of Anti-inflammatory into Products of Conception, Via Natural or Artificial Opening
KVÅKVÅ3E0E829 — Introduction of Other Anti-infective into Products of Conception, Via Natural or Artificial Opening Endoscopic
KVÅKVÅ3E0E83Z — Introduction of Anti-inflammatory into Products of Conception, Via Natural or Artificial Opening Endoscopic
KVÅKVÅ3E0F729 — Introduction of Other Anti-infective into Respiratory Tract, Via Natural or Artificial Opening
KVÅKVÅ3E0F73Z — Introduction of Anti-inflammatory into Respiratory Tract, Via Natural or Artificial Opening
KVÅKVÅ3E0F829 — Introduction of Other Anti-infective into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
KVÅKVÅ3E0F83Z — Introduction of Anti-inflammatory into Respiratory Tract, Via Natural or Artificial Opening Endoscopic